UK approves gene therapy trial for glioma:
This article was originally published in Clinica
The UK's Gene Therapy Advisory Committee (GTAC) has approved the launch of a large-scale clinical trial of a new treatment for glioma. Glioma is one of the most aggressive types of brain tumours and for which there is currently no cure. The technique being studied by Glasgow University's neurovirology department, led by Professor Moira Brown, involves injecting a Herpes simplex virus - modified to target cancerous cells but leave normal cells undamaged - into the tumour. GTAC has approved 90 gene therapy clinical trials involving over 700 patients, since 1993. 72% of these are for cancer.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.